Clinical trial

QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF

NCT02780180

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE2

Study timeline

Study start (unknown)2016-06-01Date precision: month

Registry last updated2018-10-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

QGC001DRUG

PlaceboDRUG

Sponsors & collaborators

Quantum Genomics SAlead sponsor

Mapped research locations

ParisFrance2 BudapestHungary2 BerlinGermany1 PragueCzechia1 ToulouseFrance1 MontpellierFrance1 StrasbourgFrance1 LodzPoland1 NantesFrance1 WroclawPoland1 HanoverGermany1 GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02780180 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.